Medical Specialties · attribution context sourced from stored price moves, stored event labels, and peer-relative residuals inside the XLV constituent company universe.
Review priority 100 · Source rank 0 · Volume 6.1x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +2.68% · Sector -1.85% · Industry +0.10% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -18.81%Review priority 80 · Source rank 0 · Volume 4.5x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.41% · Sector +0.44% · Industry -0.88% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -8.93%Review priority 78 · Source rank 0 · Volume 3.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.39% · Sector -1.54% · Industry +0.87% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +9.65%Review priority 75 · Source rank 0 · Volume 2.6x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.95% · Sector -0.74% · Industry +0.42% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +9.30%Review priority 67 · Source rank 54 · Volume 1.1x
Source gap missing_reliable_context_label · Next action research_macro_sector_and_company_news
Decomposition: Macro +10.34% · Sector -4.79% · Industry +3.67% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +8.37%Review priority 67 · Source rank 60 · Volume 2.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.88% · Sector -0.45% · Industry -0.74% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -6.07%Review priority 66 · Source rank 60 · Volume 2.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +1.15% · Sector +0.31% · Industry +0.93% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +6.05%| Date | Label | Move | Residual after context | Scope | Confidence |
|---|---|---|---|---|---|
| Mar 24, 2020 | Broad market moved +10.34% with this stock | +17.59% | +8.37% | Macro | 58% |
| Oct 26, 2023 | Closest peers moved -2.06% with this stock | -8.14% | -6.07% | Peer | 58% |
| Jan 15, 2019 | Closest peers moved +2.38% with this stock | +8.43% | +6.05% | Peer | 58% |
| Jul 25, 2024 | Edwards Lifesciences Corporation 8-K: 8-K | -31.34% | -2.36% | Direct | 70% |
| Jul 25, 2024 | NYSE:EW 8-K current report items 2.02,7.01,8.01 | -31.34% | -2.36% | Direct | 94% |
| Mar 16, 2020 | Broad market moved -12.13% with this stock | -10.66% | -1.97% | Macro | 58% |
| Apr 1, 2020 | Closest peers moved -4.59% with this stock | -8.48% | -3.88% | Peer | 58% |